RPNMF yields 137.93% · JNJ yields 2.13%● Live data
📍 RPNMF pulled ahead of the other in Year 1
Combined, RPNMF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RPNMF + JNJ for your $10,000?
Rapala VMC Corporation, together with its subsidiaries, engages in manufacturing, sourcing, and distributing fishing tackle products in North America, Nordic countries, rest of Europe, and internationally. It operates through two segments, Group Products and Third Party Products. The company offers products used in lures for hard baits, and also for fishing accessories, clothing, luggage, and eyewear; metal lures specifically designed for salmon and trout fishing, and trolling in fresh and salt water; braided and monofilament lines, and specialized leader lines; hooks used for sport fishing and commercial hooks, and terminal tackles; hard baits, hybrids and rigged, and unrigged soft baits; specialized trolling lures and metal jigs for saltwater big game fishing; baits for carp, match, and coarse fishing; and knives for filleting, outdoor, hunting, and kitchen use, as well as ice augers and auger blades, and cross country skis. Its brand portfolio includes Rapala and other international brands, such as VMC, Sufix, Storm, Blue Fox, Luhr Jensen, Williamson, Dynamite Baits, Mora Ice, Trigger, Marttiini, and Peltonen. Rapala VMC Corporation was founded in 1936 and is based in Helsinki, Finland.
Full RPNMF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.